| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 3.13e-05 | 10 | 130 | 3 | GO:0004679 | |
| GeneOntologyMolecularFunction | histone H2BS36 kinase activity | 4.21e-05 | 2 | 130 | 2 | GO:0140823 | |
| GeneOntologyMolecularFunction | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity | 4.21e-05 | 2 | 130 | 2 | GO:0047322 | |
| GeneOntologyMolecularFunction | histone H2B kinase activity | 4.21e-05 | 2 | 130 | 2 | GO:0140998 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 3.79e-04 | 22 | 130 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | histone H3K27me2/H3K27me3 demethylase activity | 4.15e-04 | 5 | 130 | 2 | GO:0071558 | |
| GeneOntologyMolecularFunction | protein kinase activity | ERBB2 VRK3 CRIM1 PSKH1 SGK2 SGK3 PRKAA1 PRKAA2 MARK4 ROCK1 PRKCG PRKAG2 | 5.57e-04 | 600 | 130 | 12 | GO:0004672 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 6.86e-04 | 446 | 130 | 10 | GO:0004674 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 7.84e-04 | 28 | 130 | 3 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.06e-03 | 31 | 130 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | MYC EBF3 GATA1 E2F3 RFX6 KLF4 HOXA9 NFATC2 GLIS1 NOTCH2 SMAD4 | 1.10e-03 | 560 | 130 | 11 | GO:0001228 |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.16e-03 | 32 | 130 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | MYC EBF3 GATA1 E2F3 RFX6 KLF4 HOXA9 NFATC2 GLIS1 NOTCH2 SMAD4 | 1.20e-03 | 566 | 130 | 11 | GO:0001216 |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 ARHGAP32 ERBB2 FAT4 HECW1 SZT2 MYO9A SPIRE1 KLF4 CRMP1 TBC1D24 PTPRG NFATC4 PTPRZ1 DOCK7 ROCK1 TNXB PALLD UNC5D PLXNA2 NOTCH2 PLXNB3 SMAD4 SEZ6 | 1.45e-06 | 1285 | 130 | 24 | GO:0031175 |
| GeneOntologyBiologicalProcess | left ventricular cardiac muscle tissue morphogenesis | 8.41e-06 | 7 | 130 | 3 | GO:0003220 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | FNDC3B FAT4 RARA MYO9A NUMA1 GATA1 RFX6 KDM6B KLF4 WNT5B SCUBE1 F11R ROCK1 MARVELD2 PERCC1 PALLD NOTCH2 SMAD4 | 8.98e-06 | 870 | 130 | 18 | GO:0030855 |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 1.05e-05 | 119 | 130 | 7 | GO:0010586 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TANC2 ARHGAP32 ERBB2 HECW1 SZT2 MYO9A TBC1D24 NFATC4 PTPRZ1 DOCK7 ROCK1 PALLD UNC5D PLXNA2 NOTCH2 PLXNB3 SMAD4 | 1.19e-05 | 802 | 130 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | neuron development | TANC2 ARHGAP32 ERBB2 FAT4 HECW1 SZT2 MYO9A SPIRE1 KLF4 CRMP1 TBC1D24 PTPRG NFATC4 PTPRZ1 DOCK7 ROCK1 TNXB PALLD UNC5D PLXNA2 NOTCH2 PLXNB3 SMAD4 SEZ6 | 1.33e-05 | 1463 | 130 | 24 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 1.42e-05 | 83 | 130 | 6 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 1.52e-05 | 84 | 130 | 6 | GO:0061614 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TANC2 ARHGAP32 ERBB2 HECW1 SZT2 MYO9A TBC1D24 NFATC4 PTPRZ1 DOCK7 ROCK1 PALLD UNC5D PLXNA2 NOTCH2 PLXNB3 SMAD4 | 1.56e-05 | 819 | 130 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 ARHGAP32 ERBB2 HECW1 SZT2 MYO9A TBC1D24 NFATC4 PTPRZ1 DOCK7 ROCK1 PALLD UNC5D PLXNA2 NOTCH2 PLXNB3 SMAD4 | 1.74e-05 | 826 | 130 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | MYC FAT4 RARA MYO9A KDM6B KLK3 KLF4 AHDC1 AXIN1 WNT5B ESRP2 NFATC4 CSMD1 KLK2 NOTCH2 SMAD4 | 2.04e-05 | 750 | 130 | 16 | GO:0048729 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | ARHGAP32 ERBB2 RASA2 MYO9A ARHGAP30 KLK3 DENND4C F11R DOCK7 ROCK1 KLK2 NOTCH2 PLCE1 | 3.62e-05 | 538 | 130 | 13 | GO:0007264 |
| GeneOntologyBiologicalProcess | epithelium development | MYC FNDC3B FAT4 RARA MYO9A NUMA1 GATA1 RFX6 KDM6B KLF4 WNT5B ESRP2 SCUBE1 F11R NFATC4 ROCK1 MARVELD2 CSMD1 PERCC1 PALLD PLXNA2 NOTCH2 SMAD4 | 4.30e-05 | 1469 | 130 | 23 | GO:0060429 |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 4.84e-05 | 103 | 130 | 6 | GO:2000628 | |
| GeneOntologyBiologicalProcess | regulation of stress granule assembly | 5.16e-05 | 12 | 130 | 3 | GO:0062028 | |
| GeneOntologyBiologicalProcess | regulation of cell development | MYC ARHGAP32 ERBB2 RARA TMEM176B GATA1 TBC1D24 HOXA9 FBN1 F11R NFATC4 PTPRZ1 DOCK7 ROCK1 CCL23 PLXNA2 NOTCH2 PLXNB3 SMAD4 | 5.66e-05 | 1095 | 130 | 19 | GO:0060284 |
| GeneOntologyBiologicalProcess | cell fate commitment | 5.73e-05 | 338 | 130 | 10 | GO:0045165 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 ARHGAP32 ERBB2 HECW1 SZT2 MYO9A GATA1 TBC1D24 AGO4 F11R NFATC4 PTPRZ1 DOCK7 ROCK1 PALLD UNC5D PLXNA2 NOTCH2 PLXNB3 SMAD4 | 5.78e-05 | 1194 | 130 | 20 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 ARHGAP32 ERBB2 HECW1 SZT2 TBC1D24 NFATC4 PTPRZ1 DOCK7 PALLD UNC5D PLXNA2 NOTCH2 PLXNB3 SMAD4 | 7.56e-05 | 748 | 130 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | MYC FNDC3B ERBB2 RARA TMEM176B CRIM1 GATA1 KLK3 KLF4 AXIN1 HOXA9 FBN1 ADAMTS7 NFATC2 NFATC4 PTPRZ1 ROCK1 CCL23 GLIS1 SMAD4 | 7.77e-05 | 1220 | 130 | 20 | GO:0051093 |
| GeneOntologyBiologicalProcess | tissue kallikrein-kinin cascade | 1.18e-04 | 3 | 130 | 2 | GO:0002255 | |
| GeneOntologyBiologicalProcess | axon development | ARHGAP32 ERBB2 SZT2 KLF4 TBC1D24 PTPRZ1 DOCK7 PALLD UNC5D PLXNA2 NOTCH2 PLXNB3 SMAD4 | 2.12e-04 | 642 | 130 | 13 | GO:0061564 |
| GeneOntologyBiologicalProcess | kidney mesenchyme morphogenesis | 2.35e-04 | 4 | 130 | 2 | GO:0072131 | |
| GeneOntologyBiologicalProcess | metanephric mesenchyme morphogenesis | 2.35e-04 | 4 | 130 | 2 | GO:0072133 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 2.35e-04 | 4 | 130 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | protein localization to lipid droplet | 2.35e-04 | 4 | 130 | 2 | GO:1990044 | |
| GeneOntologyBiologicalProcess | bradykinin biosynthetic process | 2.35e-04 | 4 | 130 | 2 | GO:0002936 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 3.11e-04 | 269 | 130 | 8 | GO:0002064 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 3.23e-04 | 52 | 130 | 4 | GO:0071526 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TANC2 ARHGAP32 HECW1 MYO9A KLF4 CRMP1 TBC1D24 PTPRG NFATC4 PTPRZ1 MARK4 PLXNA2 PLXNB3 SEZ6 PLCE1 | 3.57e-04 | 863 | 130 | 15 | GO:0031344 |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | MYC FNDC3B ERBB2 RARA TMEM176B CRIM1 AXIN1 HOXA9 FBN1 ADAMTS7 NFATC2 NFATC4 CCL23 GLIS1 SMAD4 | 4.13e-04 | 875 | 130 | 15 | GO:0045596 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | MYC ERBB2 VRK3 GATA1 ANKLE2 AXIN1 FBN1 FBH1 PTPRZ1 PRKAA1 PRKAA2 DOCK7 ROCK1 PRKAG2 NOTCH2 | 4.33e-04 | 879 | 130 | 15 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | MYC ERBB2 VRK3 GATA1 ANKLE2 AXIN1 FBN1 FBH1 PTPRZ1 PRKAA1 PRKAA2 DOCK7 ROCK1 PRKAG2 NOTCH2 | 4.33e-04 | 879 | 130 | 15 | GO:0010562 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | TANC2 ARHGAP32 ERBB2 HECW1 MYO9A SPIRE1 KLK3 KLF4 TBC1D24 WNT5B AGO4 F11R NFATC4 PTPRZ1 ROCK1 PLXNA2 PLXNB3 | 4.98e-04 | 1090 | 130 | 17 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | TANC2 ARHGAP32 HECW1 KLF4 CRMP1 TBC1D24 PTPRG NFATC4 PTPRZ1 PLXNA2 PLXNB3 SEZ6 | 4.99e-04 | 612 | 130 | 12 | GO:0010975 |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 5.01e-04 | 158 | 130 | 6 | GO:0045446 | |
| GeneOntologyBiologicalProcess | cardiac left ventricle morphogenesis | 5.08e-04 | 25 | 130 | 3 | GO:0003214 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron migration | 5.08e-04 | 25 | 130 | 3 | GO:2001224 | |
| GeneOntologyBiologicalProcess | skeletal system development | MYC FAT4 RARA CR2 AXIN1 HOXA9 FBN1 FBN2 ADAMTS7 NFATC2 ANKRD11 NOTCH2 | 5.21e-04 | 615 | 130 | 12 | GO:0001501 |
| GeneOntologyBiologicalProcess | kinin cascade | 5.82e-04 | 6 | 130 | 2 | GO:0002254 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 5.95e-04 | 61 | 130 | 4 | GO:1902895 | |
| GeneOntologyBiologicalProcess | regulation of neuron migration | 6.33e-04 | 62 | 130 | 4 | GO:2001222 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide catabolic process | 6.73e-04 | 63 | 130 | 4 | GO:0030811 | |
| GeneOntologyBiologicalProcess | regulation of purine nucleotide catabolic process | 6.73e-04 | 63 | 130 | 4 | GO:0033121 | |
| GeneOntologyBiologicalProcess | regulation of glycolytic process | 6.73e-04 | 63 | 130 | 4 | GO:0006110 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 7.44e-04 | 307 | 130 | 8 | GO:0018105 | |
| GeneOntologyBiologicalProcess | male gonad development | 7.60e-04 | 171 | 130 | 6 | GO:0008584 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 7.83e-04 | 172 | 130 | 6 | GO:0046546 | |
| GeneOntologyBiologicalProcess | positive regulation of glycolytic process | 7.93e-04 | 29 | 130 | 3 | GO:0045821 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide catabolic process | 7.93e-04 | 29 | 130 | 3 | GO:0030813 | |
| GeneOntologyBiologicalProcess | positive regulation of purine nucleotide catabolic process | 7.93e-04 | 29 | 130 | 3 | GO:0033123 | |
| GeneOntologyBiologicalProcess | lipid droplet disassembly | 8.11e-04 | 7 | 130 | 2 | GO:1905691 | |
| GeneOntologyBiologicalProcess | negative regulation of tubulin deacetylation | 8.11e-04 | 7 | 130 | 2 | GO:1904428 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-lysine acetylation | 8.11e-04 | 7 | 130 | 2 | GO:2000758 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | MYC FNDC3B ARHGAP32 RARA NUMA1 GATA1 TBC1D24 WNT5B FBN2 F11R PTPRZ1 CCL23 TNXB PLXNA2 NOTCH2 PLXNB3 SMAD4 | 8.31e-04 | 1141 | 130 | 17 | GO:0045597 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TANC2 ARHGAP32 HECW1 KLF4 CRMP1 TBC1D24 PTPRG NFATC4 PTPRZ1 MARK4 PLXNA2 PLXNB3 SEZ6 PLCE1 | 9.12e-04 | 846 | 130 | 14 | GO:0120035 |
| GeneOntologyBiologicalProcess | axonogenesis | ARHGAP32 ERBB2 SZT2 PTPRZ1 DOCK7 PALLD UNC5D PLXNA2 NOTCH2 PLXNB3 SMAD4 | 9.23e-04 | 566 | 130 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 9.52e-04 | 319 | 130 | 8 | GO:0018209 | |
| GeneOntologyCellularComponent | nucleotide-activated protein kinase complex | 3.91e-05 | 11 | 132 | 3 | GO:0031588 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 6.72e-05 | 13 | 132 | 3 | GO:0002116 | |
| Domain | IPT | 1.12e-06 | 27 | 131 | 5 | SM00429 | |
| Domain | TIG | 2.31e-06 | 31 | 131 | 5 | PF01833 | |
| Domain | IPT | 2.72e-06 | 32 | 131 | 5 | IPR002909 | |
| Domain | Ig_E-set | 8.58e-06 | 104 | 131 | 7 | IPR014756 | |
| Domain | KA1/Ssp2_C | 1.16e-05 | 7 | 131 | 3 | IPR028375 | |
| Domain | Growth_fac_rcpt_ | 1.44e-05 | 156 | 131 | 8 | IPR009030 | |
| Domain | Rho_GTPase_activation_prot | 3.59e-05 | 88 | 131 | 6 | IPR008936 | |
| Domain | AdenylateSensor | 4.88e-05 | 2 | 131 | 2 | PF16579 | |
| Domain | AMPK_C | 4.88e-05 | 2 | 131 | 2 | IPR032270 | |
| Domain | EGF_Ca-bd_CS | 6.22e-05 | 97 | 131 | 6 | IPR018097 | |
| Domain | - | FNDC3B EBF3 TGM5 F11R PTPRG NFATC2 NFATC4 PTPRZ1 NECTIN2 TNXB PALLD UNC5D CD96 PLXNA2 PLXNB3 | 6.46e-05 | 663 | 131 | 15 | 2.60.40.10 |
| Domain | EGF_CA | 6.97e-05 | 99 | 131 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.38e-05 | 100 | 131 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.02e-04 | 106 | 131 | 6 | IPR000152 | |
| Domain | Pkinase_C | 1.28e-04 | 37 | 131 | 4 | IPR017892 | |
| Domain | Ig-like_fold | FNDC3B EBF3 TGM5 F11R PTPRG NFATC2 NFATC4 PTPRZ1 NECTIN2 TNXB PALLD UNC5D CD96 PLXNA2 PLXNB3 | 1.30e-04 | 706 | 131 | 15 | IPR013783 |
| Domain | FBN | 1.46e-04 | 3 | 131 | 2 | IPR011398 | |
| Domain | Pkinase_C | 2.10e-04 | 42 | 131 | 4 | PF00433 | |
| Domain | EGF_CA | 2.21e-04 | 122 | 131 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.41e-04 | 124 | 131 | 6 | IPR001881 | |
| Domain | EGF_CA | 3.48e-04 | 86 | 131 | 5 | PF07645 | |
| Domain | CUB | 3.84e-04 | 49 | 131 | 4 | PF00431 | |
| Domain | CUB | 4.15e-04 | 50 | 131 | 4 | SM00042 | |
| Domain | NFAT | 4.82e-04 | 5 | 131 | 2 | IPR008366 | |
| Domain | - | 4.82e-04 | 52 | 131 | 4 | 2.60.120.290 | |
| Domain | Sushi | 4.82e-04 | 52 | 131 | 4 | PF00084 | |
| Domain | CUB | 5.19e-04 | 53 | 131 | 4 | PS01180 | |
| Domain | CCP | 5.57e-04 | 54 | 131 | 4 | SM00032 | |
| Domain | JmjC | 6.13e-04 | 24 | 131 | 3 | PF02373 | |
| Domain | AGC-kinase_C | 6.40e-04 | 56 | 131 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 6.40e-04 | 56 | 131 | 4 | PS51285 | |
| Domain | S_TK_X | 6.40e-04 | 56 | 131 | 4 | SM00133 | |
| Domain | SUSHI | 6.40e-04 | 56 | 131 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 6.85e-04 | 57 | 131 | 4 | IPR000436 | |
| Domain | CUB_dom | 6.85e-04 | 57 | 131 | 4 | IPR000859 | |
| Domain | cEGF | 7.79e-04 | 26 | 131 | 3 | PF12662 | |
| Domain | cEGF | 7.79e-04 | 26 | 131 | 3 | IPR026823 | |
| Domain | Ser/Thr_kinase_AS | 9.42e-04 | 357 | 131 | 9 | IPR008271 | |
| Domain | hEGF | 9.72e-04 | 28 | 131 | 3 | PF12661 | |
| Domain | S_TKc | 9.80e-04 | 359 | 131 | 9 | SM00220 | |
| Domain | TB | 1.00e-03 | 7 | 131 | 2 | PF00683 | |
| Domain | Notch_dom | 1.00e-03 | 7 | 131 | 2 | IPR000800 | |
| Domain | Notch | 1.00e-03 | 7 | 131 | 2 | PF00066 | |
| Domain | NL | 1.00e-03 | 7 | 131 | 2 | SM00004 | |
| Domain | PROTEIN_KINASE_ST | 1.04e-03 | 362 | 131 | 9 | PS00108 | |
| Domain | - | 1.33e-03 | 8 | 131 | 2 | 3.90.290.10 | |
| Domain | EGF | 1.36e-03 | 235 | 131 | 7 | SM00181 | |
| Domain | EGF_3 | 1.36e-03 | 235 | 131 | 7 | PS50026 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 1.40e-03 | 69 | 131 | 4 | IPR020636 | |
| Domain | Protein_kinase_ATP_BS | 1.43e-03 | 379 | 131 | 9 | IPR017441 | |
| Domain | JMJC | 1.44e-03 | 32 | 131 | 3 | PS51184 | |
| Domain | JmjC_dom | 1.44e-03 | 32 | 131 | 3 | IPR003347 | |
| Domain | Pkinase | 1.48e-03 | 381 | 131 | 9 | PF00069 | |
| Domain | PROTEIN_KINASE_ATP | 1.49e-03 | 459 | 131 | 10 | PS00107 | |
| Domain | Kinase-like_dom | ERBB2 VRK3 PSKH1 WDR81 SGK2 SGK3 PRKAA1 PRKAA2 MARK4 ROCK1 PRKCG | 1.53e-03 | 542 | 131 | 11 | IPR011009 |
| Domain | JmjC | 1.58e-03 | 33 | 131 | 3 | SM00558 | |
| Domain | Plexin_cytopl | 1.70e-03 | 9 | 131 | 2 | PF08337 | |
| Domain | Ataxin-2_C | 1.70e-03 | 9 | 131 | 2 | IPR009818 | |
| Domain | TB_dom | 1.70e-03 | 9 | 131 | 2 | IPR017878 | |
| Domain | PAM2 | 1.70e-03 | 9 | 131 | 2 | PF07145 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.70e-03 | 9 | 131 | 2 | IPR013548 | |
| Domain | Plexin | 1.70e-03 | 9 | 131 | 2 | IPR031148 | |
| Domain | TB | 1.70e-03 | 9 | 131 | 2 | PS51364 | |
| Domain | EGF-like_dom | 1.89e-03 | 249 | 131 | 7 | IPR000742 | |
| Domain | RHD_dimer | 2.12e-03 | 10 | 131 | 2 | IPR032397 | |
| Domain | RHD_dimer | 2.12e-03 | 10 | 131 | 2 | PF16179 | |
| Domain | REL_1 | 2.12e-03 | 10 | 131 | 2 | PS01204 | |
| Domain | - | 2.12e-03 | 10 | 131 | 2 | 2.60.40.340 | |
| Domain | NFkB/Dor | 2.12e-03 | 10 | 131 | 2 | IPR000451 | |
| Domain | RHD_DNA_bind_dom | 2.12e-03 | 10 | 131 | 2 | IPR011539 | |
| Domain | RHD_DNA_bind | 2.12e-03 | 10 | 131 | 2 | PF00554 | |
| Domain | REL_2 | 2.12e-03 | 10 | 131 | 2 | PS50254 | |
| Domain | EGF_1 | 2.16e-03 | 255 | 131 | 7 | PS00022 | |
| Domain | C2 | 2.31e-03 | 131 | 131 | 5 | PF00168 | |
| Domain | Prot_kinase_dom | 2.37e-03 | 489 | 131 | 10 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 2.51e-03 | 493 | 131 | 10 | PS50011 | |
| Domain | EGF_2 | 2.68e-03 | 265 | 131 | 7 | PS01186 | |
| Domain | C2 | 2.81e-03 | 137 | 131 | 5 | SM00239 | |
| Domain | ZnF_GATA | 3.08e-03 | 12 | 131 | 2 | SM00401 | |
| Domain | C2 | 3.28e-03 | 142 | 131 | 5 | PS50004 | |
| Domain | - | 3.91e-03 | 148 | 131 | 5 | 2.60.40.150 | |
| Domain | Znf_GATA | 4.83e-03 | 15 | 131 | 2 | IPR000679 | |
| Domain | GATA | 4.83e-03 | 15 | 131 | 2 | PF00320 | |
| Domain | GATA_ZN_FINGER_1 | 5.49e-03 | 16 | 131 | 2 | PS00344 | |
| Domain | DENN | 5.49e-03 | 16 | 131 | 2 | SM00799 | |
| Domain | DENN | 5.49e-03 | 16 | 131 | 2 | PF02141 | |
| Domain | dDENN | 5.49e-03 | 16 | 131 | 2 | PF03455 | |
| Domain | GATA_ZN_FINGER_2 | 5.49e-03 | 16 | 131 | 2 | PS50114 | |
| Domain | UDENN | 5.49e-03 | 16 | 131 | 2 | PS50946 | |
| Domain | DDENN | 5.49e-03 | 16 | 131 | 2 | PS50947 | |
| Domain | dDENN | 5.49e-03 | 16 | 131 | 2 | SM00801 | |
| Domain | dDENN_dom | 5.49e-03 | 16 | 131 | 2 | IPR005112 | |
| Domain | uDENN_dom | 5.49e-03 | 16 | 131 | 2 | IPR005113 | |
| Domain | DENN | 5.49e-03 | 16 | 131 | 2 | PS50211 | |
| Domain | DENN_dom | 5.49e-03 | 16 | 131 | 2 | IPR001194 | |
| Domain | C2_dom | 6.02e-03 | 164 | 131 | 5 | IPR000008 | |
| Domain | Carb_anhydrase | 6.20e-03 | 17 | 131 | 2 | PF00194 | |
| Domain | Carb_anhydrase | 6.20e-03 | 17 | 131 | 2 | SM01057 | |
| Domain | - | 6.20e-03 | 17 | 131 | 2 | 3.10.200.10 | |
| Domain | ALPHA_CA_2 | 6.20e-03 | 17 | 131 | 2 | PS51144 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.25e-05 | 151 | 101 | 8 | M19428 | |
| Pathway | PID_LKB1_PATHWAY | 2.06e-05 | 47 | 101 | 5 | M87 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 3.09e-05 | 51 | 101 | 5 | MM14967 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 3.22e-05 | 85 | 101 | 6 | M48315 | |
| Pathway | WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME | 5.14e-05 | 29 | 101 | 4 | M39890 | |
| Pathway | BIOCARTA_LEPTIN_PATHWAY | 5.65e-05 | 11 | 101 | 3 | M18053 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 9.32e-05 | 64 | 101 | 5 | M7923 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 1.59e-04 | 113 | 101 | 6 | M39669 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 1.86e-04 | 74 | 101 | 5 | M39857 | |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 3.18e-04 | 19 | 101 | 3 | M22004 | |
| Pathway | KEGG_AXON_GUIDANCE | 3.26e-04 | 129 | 101 | 6 | M5539 | |
| Pathway | WP_WNT_SIGNALING_WP363 | 4.79e-04 | 51 | 101 | 4 | M39721 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 5.35e-04 | 325 | 101 | 9 | M12868 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 5.70e-04 | 23 | 101 | 3 | MM1527 | |
| Pathway | WP_OREXIN_RECEPTOR_PATHWAY | 5.81e-04 | 200 | 101 | 7 | M48048 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 6.48e-04 | 24 | 101 | 3 | M16517 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 7.32e-04 | 25 | 101 | 3 | M39713 | |
| Pathway | REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY | 7.48e-04 | 6 | 101 | 2 | MM14630 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 8.32e-04 | 154 | 101 | 6 | M39739 | |
| Pathway | WP_WNT_SIGNALING | 9.47e-04 | 61 | 101 | 4 | MM15893 | |
| Pathway | WP_CANCER_PATHWAYS | MYC ERBB2 RARA E2F3 KLK3 AXIN1 WNT5B ROCK1 PRKCG NOTCH2 SMAD4 | 9.99e-04 | 507 | 101 | 11 | M48302 |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.03e-03 | 28 | 101 | 3 | M48253 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 1.03e-03 | 28 | 101 | 3 | MM1391 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_EBNA2_TO_RBP_JK_MEDIATED_TRANSCRIPTION | 1.04e-03 | 7 | 101 | 2 | M47478 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.05e-03 | 161 | 101 | 6 | M27871 | |
| Pathway | WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS | 1.14e-03 | 29 | 101 | 3 | M39516 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 1.14e-03 | 29 | 101 | 3 | M39762 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 1.14e-03 | 29 | 101 | 3 | MM14934 | |
| Pathway | REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK | 1.14e-03 | 29 | 101 | 3 | M19861 | |
| Pathway | REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK | 1.14e-03 | 29 | 101 | 3 | MM14980 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.14e-03 | 29 | 101 | 3 | M27948 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 1.15e-03 | 110 | 101 | 5 | M39492 | |
| Pubmed | ERBB2 SZT2 SMCHD1 SPIRE1 E2F3 INO80 KDM6B ANKLE2 KIAA1614 TBC1D24 USP10 AGO4 KDM7A CEP126 | 2.12e-08 | 529 | 135 | 14 | 14621295 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 ARHGAP32 ERBB2 MYO9A SPIRE1 DENND2B DENND4C STARD9 NECTIN2 PRKAA2 MARK4 DOCK7 ANKRD11 HELZ PRKCG PALLD NOTCH2 | 4.45e-08 | 861 | 135 | 17 | 36931259 |
| Pubmed | 5.72e-08 | 3 | 135 | 3 | 36509022 | ||
| Pubmed | 5.72e-08 | 3 | 135 | 3 | 26876938 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 ERBB2 SZT2 INTS1 SPIRE1 PFAS INO80 MED13L KDM6B KLF4 AHDC1 KCNH3 TBC1D24 ESRP2 ADAMTS7 MARK4 ANKRD11 CABIN1 NOTCH2 | 5.95e-08 | 1105 | 135 | 19 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ERBB2 RASA2 RTEL1 MYO9A SPIRE1 E2F3 DENND2B AHDC1 SGK2 PLEKHH1 USP10 PTPRG AOPEP NECTIN2 PRKAA2 ANKRD11 SLC35F2 PRKAG2 CSMD1 ERMARD GLIS1 NOTCH2 | 7.00e-08 | 1489 | 135 | 22 | 28611215 |
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 24093678 | ||
| Pubmed | Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis. | 5.69e-07 | 5 | 135 | 3 | 24276244 | |
| Pubmed | AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location. | 1.13e-06 | 6 | 135 | 3 | 9224708 | |
| Pubmed | 1.13e-06 | 6 | 135 | 3 | 24563466 | ||
| Pubmed | Over-expressions of AMPK subunits in ovarian carcinomas with significant clinical implications. | 1.13e-06 | 6 | 135 | 3 | 22897928 | |
| Pubmed | 1.98e-06 | 7 | 135 | 3 | 31983282 | ||
| Pubmed | Glucose recruits K(ATP) channels via non-insulin-containing dense-core granules. | 1.98e-06 | 7 | 135 | 3 | 17767908 | |
| Pubmed | MiR-184 expression is regulated by AMPK in pancreatic islets. | 1.98e-06 | 7 | 135 | 3 | 29269398 | |
| Pubmed | 1.98e-06 | 7 | 135 | 3 | 10698692 | ||
| Pubmed | 3.16e-06 | 8 | 135 | 3 | 23184942 | ||
| Pubmed | 3.16e-06 | 8 | 135 | 3 | 10098881 | ||
| Pubmed | 3.16e-06 | 8 | 135 | 3 | 20821366 | ||
| Pubmed | TSC2 mediates cellular energy response to control cell growth and survival. | 4.72e-06 | 9 | 135 | 3 | 14651849 | |
| Pubmed | The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK. | 4.72e-06 | 9 | 135 | 3 | 36217034 | |
| Pubmed | AMPK phosphorylation of raptor mediates a metabolic checkpoint. | 4.72e-06 | 9 | 135 | 3 | 18439900 | |
| Pubmed | STK11 is required for the normal program of ciliated cell differentiation in airways. | 6.30e-06 | 31 | 135 | 4 | 31636950 | |
| Pubmed | 6.62e-06 | 251 | 135 | 8 | 29031500 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 6.63e-06 | 424 | 135 | 10 | 21731673 | |
| Pubmed | SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase. | 6.73e-06 | 10 | 135 | 3 | 19720090 | |
| Pubmed | 9.22e-06 | 11 | 135 | 3 | 8666393 | ||
| Pubmed | 9.22e-06 | 11 | 135 | 3 | 27430620 | ||
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 21344388 | ||
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 8288260 | ||
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 32807950 | ||
| Pubmed | 1.30e-05 | 37 | 135 | 4 | 1981054 | ||
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 1.45e-05 | 38 | 135 | 4 | 12482669 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ARHGAP32 DCBLD1 TBC1D24 F11R PTPRG NECTIN2 DOCK7 ROCK1 SLC35F2 PLXNA2 NOTCH2 | 1.47e-05 | 569 | 135 | 11 | 30639242 |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12399449 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24270797 | ||
| Pubmed | Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells. | 1.50e-05 | 2 | 135 | 2 | 23089465 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21851253 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21673972 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 18801964 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21947382 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 32839348 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20465544 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 1.50e-05 | 2 | 135 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 1.50e-05 | 2 | 135 | 2 | 21440062 | |
| Pubmed | Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase. | 1.50e-05 | 2 | 135 | 2 | 19236843 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 15131124 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 17657743 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 23905686 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 32504885 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 37914528 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19003994 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 31540695 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 27600021 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 23486478 | ||
| Pubmed | Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. | 1.50e-05 | 2 | 135 | 2 | 15878932 | |
| Pubmed | ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc. | 1.50e-05 | 2 | 135 | 2 | 24317511 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 1.50e-05 | 2 | 135 | 2 | 20404337 | |
| Pubmed | AMPK activation regulates neuronal structure in developing hippocampal neurons. | 1.50e-05 | 2 | 135 | 2 | 24295634 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 1.50e-05 | 2 | 135 | 2 | 8791520 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22751120 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22763120 | ||
| Pubmed | AMP-activated protein kinase phosphorylates and inactivates liver glycogen synthase. | 1.50e-05 | 2 | 135 | 2 | 22233421 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 1.50e-05 | 2 | 135 | 2 | 8307578 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26843621 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24711254 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21209024 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24855056 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26419588 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 1.50e-05 | 2 | 135 | 2 | 7744963 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 28974562 | ||
| Pubmed | Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. | 1.50e-05 | 2 | 135 | 2 | 12546688 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 18258606 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26408953 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12788940 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 38019084 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 1.50e-05 | 2 | 135 | 2 | 18006876 | |
| Pubmed | The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma. | 1.50e-05 | 2 | 135 | 2 | 34347929 | |
| Pubmed | Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK. | 1.50e-05 | 2 | 135 | 2 | 31693892 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 1.50e-05 | 2 | 135 | 2 | 24833718 | |
| Pubmed | ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of human keratinocytes. | 1.50e-05 | 2 | 135 | 2 | 27556514 | |
| Pubmed | Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer's model mice. | 1.50e-05 | 2 | 135 | 2 | 32213711 | |
| Pubmed | AMPK knockdown in placental trophoblast cells results in altered morphology and function. | 1.50e-05 | 2 | 135 | 2 | 25003940 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 29928235 | ||
| Pubmed | [AMPK as a Metabolic Intersection between Diet and Physical Exercise]. | 1.50e-05 | 2 | 135 | 2 | 30270274 | |
| Pubmed | AMPK regulates circadian rhythms in a tissue- and isoform-specific manner. | 1.50e-05 | 2 | 135 | 2 | 21483791 | |
| Pubmed | AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. | 1.50e-05 | 2 | 135 | 2 | 20399918 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 34767944 | ||
| Pubmed | Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression. | 1.50e-05 | 2 | 135 | 2 | 34862309 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24265020 | ||
| Pubmed | Involvement of AMPK in regulating slow-twitch muscle atrophy during hindlimb unloading in mice. | 1.50e-05 | 2 | 135 | 2 | 26244519 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20529844 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12091379 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24665903 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20830737 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22119190 | ||
| Pubmed | Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy. | 1.50e-05 | 2 | 135 | 2 | 16275868 | |
| Pubmed | Protein expression alteration in hippocampus upon genetic repression of AMPKα isoforms. | 1.50e-05 | 2 | 135 | 2 | 33492732 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 27855169 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 29038293 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 23133647 | ||
| GeneFamily | DNA helicases | 8.23e-05 | 17 | 92 | 3 | 1167 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.02e-04 | 57 | 92 | 4 | 1179 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 2.39e-04 | 24 | 92 | 3 | 485 | |
| GeneFamily | Nuclear factors of activated T-cells | 2.54e-04 | 5 | 92 | 2 | 665 | |
| GeneFamily | Plexins | 9.01e-04 | 9 | 92 | 2 | 683 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.58e-03 | 15 | 92 | 2 | 82 | |
| GeneFamily | Kallikreins | 2.93e-03 | 16 | 92 | 2 | 616 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | LYPD4 ERBB2 SZT2 NUMA1 INO80 KDM5D WNT5B LARP4B PTPRZ1 ANKRD11 CABIN1 PALLD NOTCH2 PLXNB3 PLCE1 | 6.72e-06 | 746 | 134 | 15 | M40863 |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP | 8.83e-06 | 199 | 134 | 8 | M9366 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN | 9.16e-06 | 200 | 134 | 8 | M6585 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | FNDC3B CRIM1 RASA2 SPIRE1 KLK3 KLF4 DENND2B SGK3 AGO4 PTPRG PRKAA1 ROCK1 KDM7A KLK2 PALLD PLCE1 | 1.28e-05 | 888 | 134 | 16 | MM1018 |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | RARA EBF3 RFX6 NBPF11 KLF4 CR2 ADARB2 CRMP1 KCNH3 WNT5B HOXA9 FBN1 FBN2 PAPPA PRKAG2 CSMD1 PLXNA2 SEZ6 | 1.57e-05 | 1115 | 134 | 18 | M10371 |
| Coexpression | DUAN_PRDM5_TARGETS | 4.77e-05 | 77 | 134 | 5 | M2339 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | FNDC3B ERBB2 RARA CRIM1 KDM5D USP37 KLK3 DENND2B KIAA1614 SGK3 STARD9 MARK4 DOCK7 PAPPA N4BP1 KDM7A MARVELD2 NOTCH2 PLCE1 | 2.20e-06 | 880 | 132 | 19 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | FNDC3B ERBB2 RARA SZT2 KDM5D USP37 KLK3 DENND2B KIAA1614 SGK3 SCUBE1 STARD9 MARK4 DOCK7 FAM83D N4BP1 KDM7A NOTCH2 PLCE1 | 2.36e-06 | 884 | 132 | 19 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | FAT4 SZT2 MYO9A DCBLD1 E2F3 THSD7B KLF4 DENND2B DENND4C SCUBE1 FBN1 FBN2 F11R PTPRG PALLD PLXNA2 NOTCH2 | 7.38e-06 | 783 | 132 | 17 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | MYC FAT4 GPR19 RARA TMEM176B SZT2 MYO9A KDM5D KLK3 KIAA1614 FBN1 FBN2 PTPRG ADAMTS7 NFATC4 PTPRZ1 AOPEP RPUSD3 PAPPA PALLD PLCE1 | 1.76e-05 | 1208 | 132 | 21 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.63e-05 | 191 | 132 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_1000 | FNDC3B ERBB2 RARA KDM5D KIAA1614 SGK3 STARD9 DOCK7 PAPPA KDM7A NOTCH2 PLCE1 | 4.13e-05 | 474 | 132 | 12 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k4_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | FAT4 MYO9A DCBLD1 THSD7B DENND2B DENND4C SCUBE1 FBN1 FBN2 PALLD | 8.08e-05 | 357 | 132 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.12e-05 | 224 | 132 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_1000 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-08 | 159 | 135 | 8 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.42e-08 | 181 | 135 | 8 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.79e-08 | 182 | 135 | 8 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-08 | 184 | 135 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-08 | 184 | 135 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-08 | 184 | 135 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.04e-07 | 164 | 135 | 7 | 35c673380f75cb4bfe080089bc723c4373bcc7a5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.32e-07 | 171 | 135 | 7 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-06 | 175 | 135 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-06 | 178 | 135 | 7 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-06 | 179 | 135 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-06 | 180 | 135 | 7 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-06 | 181 | 135 | 7 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-06 | 182 | 135 | 7 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-06 | 184 | 135 | 7 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.63e-06 | 186 | 135 | 7 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.63e-06 | 186 | 135 | 7 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-06 | 187 | 135 | 7 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.69e-06 | 187 | 135 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-06 | 188 | 135 | 7 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-06 | 190 | 135 | 7 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-06 | 191 | 135 | 7 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.09e-06 | 193 | 135 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-06 | 196 | 135 | 7 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-06 | 196 | 135 | 7 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-06 | 196 | 135 | 7 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.64e-06 | 200 | 135 | 7 | 691b3edf7d8449556e8bf611662eb85772959f0f | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.64e-06 | 200 | 135 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 200 | 135 | 7 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.64e-06 | 200 | 135 | 7 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.64e-06 | 200 | 135 | 7 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.64e-06 | 200 | 135 | 7 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 165 | 135 | 6 | 50a8513d8d2630861499393a7f102b35366bad37 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 170 | 135 | 6 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 172 | 135 | 6 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-2_PAX6_SCGN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-05 | 173 | 135 | 6 | 33170a1cc0bc87504d0501fc257a32ff17e02314 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-05 | 175 | 135 | 6 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-05 | 175 | 135 | 6 | 5a9160a9d05e01d945e77fd81bb0bd87139545cd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-05 | 176 | 135 | 6 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-05 | 176 | 135 | 6 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-05 | 179 | 135 | 6 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 181 | 135 | 6 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-05 | 181 | 135 | 6 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 181 | 135 | 6 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-05 | 181 | 135 | 6 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 181 | 135 | 6 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-05 | 182 | 135 | 6 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 183 | 135 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 184 | 135 | 6 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 185 | 135 | 6 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 185 | 135 | 6 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 2.16e-05 | 185 | 135 | 6 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.22e-05 | 186 | 135 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-05 | 187 | 135 | 6 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-05 | 187 | 135 | 6 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-05 | 188 | 135 | 6 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-05 | 188 | 135 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-05 | 192 | 135 | 6 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 192 | 135 | 6 | 959c28d28397bc0b9d3970d1fe3293d2750e63d4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-05 | 192 | 135 | 6 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 192 | 135 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 194 | 135 | 6 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | ILEUM-inflamed-(6)_ILC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.82e-05 | 194 | 135 | 6 | 4d51d49366c34ff1241770b4acc0167a43b3155a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-05 | 197 | 135 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-05 | 197 | 135 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.07e-05 | 197 | 135 | 6 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.16e-05 | 198 | 135 | 6 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 198 | 135 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.16e-05 | 198 | 135 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-05 | 199 | 135 | 6 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | medial-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.25e-05 | 199 | 135 | 6 | 95aae608fa35a9c82b12c6f18937ce636750ca44 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.25e-05 | 199 | 135 | 6 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | medial-mesenchymal-Myofibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.25e-05 | 199 | 135 | 6 | e25acdb5809aaff631cb06dbe4c7e59549a0bdb9 | |
| ToppCell | medial-mesenchymal-Myofibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.25e-05 | 199 | 135 | 6 | 9ebf4822ff9fa08574edec5dbf4f2a1488f34b1d | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1-L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 2086024ce808b8796ed508a229b098eb02f8828a | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.34e-05 | 200 | 135 | 6 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 35951db6a4f442ac9e13f1b8cc5b4a33481f92c8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 140aff451cd58e1d544ee668e49e37e577f6f068 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 48303e499251d6754cfa991dc2d96c5563b2123c | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.34e-05 | 200 | 135 | 6 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.34e-05 | 200 | 135 | 6 | 16a3685c41194a0a4a772e4eee372160263480e0 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 85bfa7f4dd07a4d4a88330e88f5886fd1ecfdeeb | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.34e-05 | 200 | 135 | 6 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 4802dd6cae84b41746227a5d1aa1c9b858495e36 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.34e-05 | 200 | 135 | 6 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.34e-05 | 200 | 135 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-05 | 128 | 135 | 5 | 076ba9de63b9a4b5a2f7e7924b9a86e8eafce91f | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.61e-05 | 129 | 135 | 5 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.13e-05 | 149 | 135 | 5 | f53151d9e5e724a61be0ee6a8c740d1990f28d5f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.13e-05 | 149 | 135 | 5 | 9286bc56ff2e245630537a0bda5f1a1e17be863a | |
| ToppCell | E17.5-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.43e-05 | 150 | 135 | 5 | 201d5b68e71c6c003285428be96c488e6d526edf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-04 | 153 | 135 | 5 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 154 | 135 | 5 | cd99428c282d566b5dbd31fd5a0371b7ffe9ffa2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-04 | 155 | 135 | 5 | 99e749f7075e2c64e9a0bf91009f95b6969197c8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-04 | 155 | 135 | 5 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 156 | 135 | 5 | a4b0e89255ea5d60198cb2b3e739981f9c9cf5c5 | |
| Disease | body surface area | FNDC3B CRIM1 SMCHD1 CYP21A2 MED13L KCNB2 AXIN1 FBN1 FBN2 ADO PTPRG AOPEP ANKRD11 PAPPA | 1.22e-06 | 643 | 132 | 14 | EFO_0022196 |
| Disease | acute promyelocytic leukemia (is_implicated_in) | 3.02e-06 | 7 | 132 | 3 | DOID:0060318 (is_implicated_in) | |
| Disease | Hereditary Diffuse Gastric Cancer | 7.25e-06 | 293 | 132 | 9 | C1708349 | |
| Disease | Stomach Neoplasms | 8.08e-06 | 297 | 132 | 9 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 8.76e-06 | 300 | 132 | 9 | C0024623 | |
| Disease | cystatin C measurement | CYP21A2 E2F3 USP37 ADARB2 TBC1D24 LARP4B NECTIN2 ANKRD11 PRKAG2 GLIS1 | 1.41e-05 | 402 | 132 | 10 | EFO_0004617 |
| Disease | urinary albumin to creatinine ratio | 1.67e-05 | 179 | 132 | 7 | EFO_0007778 | |
| Disease | ACUTE PROMYELOCYTIC LEUKEMIA | 1.99e-05 | 2 | 132 | 2 | 612376 | |
| Disease | Acute promyelocytic leukemia | 1.99e-05 | 2 | 132 | 2 | cv:C0023487 | |
| Disease | coronary artery disease | FNDC3B FAT4 INO80 KCNB2 ADARB2 DENND2B AHDC1 SCUBE1 FBN2 OIT3 ADAMTS7 TRPM3 MARK4 CABIN1 TNXB PALLD PLCE1 | 2.50e-05 | 1194 | 132 | 17 | EFO_0001645 |
| Disease | pulse pressure measurement | FNDC3B GPR19 CRIM1 INO80 MED13L KDM6B AHDC1 DENND4C HOXA9 FBN1 FBN2 ADO NFATC2 TRPM3 ANKRD11 PRKAG2 PALLD PLCE1 | 4.99e-05 | 1392 | 132 | 18 | EFO_0005763 |
| Disease | connective tissue disease (implicated_via_orthology) | 5.94e-05 | 3 | 132 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 1.18e-04 | 4 | 132 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | triacylglycerol 58:9 measurement | 1.27e-04 | 22 | 132 | 3 | EFO_0010443 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.38e-04 | 335 | 132 | 8 | EFO_0009931 | |
| Disease | creatinine measurement | CYP21A2 E2F3 INO80 KLF4 ADARB2 KIAA1614 CRMP1 USP10 LARP4B ADAMTS7 NECTIN2 DOCK7 ANKRD11 PRKAG2 | 1.54e-04 | 995 | 132 | 14 | EFO_0004518 |
| Disease | Intrahepatic Cholangiocarcinoma | 1.65e-04 | 24 | 132 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.65e-04 | 24 | 132 | 3 | C3805278 | |
| Disease | Carcinoma, Granular Cell | 1.79e-04 | 116 | 132 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.79e-04 | 116 | 132 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.79e-04 | 116 | 132 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.79e-04 | 116 | 132 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.79e-04 | 116 | 132 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 1.79e-04 | 116 | 132 | 5 | C0001418 | |
| Disease | total blood protein measurement | 1.97e-04 | 449 | 132 | 9 | EFO_0004536 | |
| Disease | Cholangiocarcinoma | 2.11e-04 | 26 | 132 | 3 | C0206698 | |
| Disease | amino acid measurement | TANC2 FAT4 CYP21A2 ADARB2 TGM5 WNT5B PTPRG MARK4 CSMD1 UNC5D PLXNA2 | 2.44e-04 | 678 | 132 | 11 | EFO_0005134 |
| Disease | serum urea measurement | 2.53e-04 | 195 | 132 | 6 | EFO_0009795 | |
| Disease | renal cell carcinoma (is_marker_for) | 2.83e-04 | 128 | 132 | 5 | DOID:4450 (is_marker_for) | |
| Disease | phosphatidylcholine measurement | 3.01e-04 | 284 | 132 | 7 | EFO_0010226 | |
| Disease | Alzheimer disease | 3.47e-04 | 485 | 132 | 9 | MONDO_0004975 | |
| Disease | Helicobacter Infections | 4.11e-04 | 7 | 132 | 2 | C0079487 | |
| Disease | obesity (implicated_via_orthology) | 4.26e-04 | 215 | 132 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | uric acid measurement | FAT4 CRIM1 MYO9A CYP21A2 PLEKHH1 LARP4B NFATC2 MARK4 PRKAG2 GLIS1 | 4.33e-04 | 610 | 132 | 10 | EFO_0004761 |
| Disease | red blood cell density measurement | MYO9A PSKH1 CYP21A2 INO80 KDM6B DENND2B HOXA9 LARP4B ADO TRPM3 MARK4 PRKAG2 | 6.09e-04 | 880 | 132 | 12 | EFO_0007978 |
| Disease | cataract (implicated_via_orthology) | 6.58e-04 | 38 | 132 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | descending aortic diameter | 6.67e-04 | 88 | 132 | 4 | EFO_0021788 | |
| Disease | Pancreatic carcinoma, familial | 7.00e-04 | 9 | 132 | 2 | C2931038 | |
| Disease | Cleft upper lip | 7.11e-04 | 39 | 132 | 3 | C0008924 | |
| Disease | Neoplasm Recurrence, Local | 7.11e-04 | 39 | 132 | 3 | C0027643 | |
| Disease | lung cancer (is_marker_for) | 7.11e-04 | 39 | 132 | 3 | DOID:1324 (is_marker_for) | |
| Disease | basophil count, eosinophil count | 7.75e-04 | 241 | 132 | 6 | EFO_0004842, EFO_0005090 | |
| Disease | monocyte count | RASA2 SZT2 ARHGAP30 MED13L DENND2B AHDC1 KIAA1614 SGK2 SGK3 HOXA9 ADO LYPD5 MARK4 CABIN1 PLCE1 | 8.50e-04 | 1320 | 132 | 15 | EFO_0005091 |
| Disease | albuminuria | 8.55e-04 | 94 | 132 | 4 | EFO_0004285 | |
| Disease | lymphocyte count | CYP21A2 E2F3 MED13L ANKLE2 FBN1 ADO ZGLP1 NFATC2 NECTIN2 PRKAA2 MARK4 ANKRD11 HELZ PAPPA NOTCH2 PLCE1 | 8.59e-04 | 1464 | 132 | 16 | EFO_0004587 |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 8.73e-04 | 10 | 132 | 2 | EFO_0022035 | |
| Disease | Squamous cell carcinoma of esophagus | 8.89e-04 | 95 | 132 | 4 | C0279626 | |
| Disease | Adenocarcinoma of large intestine | 9.25e-04 | 96 | 132 | 4 | C1319315 | |
| Disease | eosinophil count | RASA2 CYP21A2 GATA1 RFX6 KDM6B ANKLE2 LARP4B ADO NFATC2 NECTIN2 MARK4 ANKRD11 N4BP1 TNXB NOTCH2 SMAD4 | 1.02e-03 | 1488 | 132 | 16 | EFO_0004842 |
| Disease | cortical surface area measurement | TANC2 CYP21A2 MED13L KIAA1614 AXIN1 SCUBE1 FBN1 FBN2 ADAMTS7 AOPEP PAPPA PRKAG2 TNXB PLXNA2 PLCE1 | 1.03e-03 | 1345 | 132 | 15 | EFO_0010736 |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.06e-03 | 11 | 132 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Mammary Ductal Carcinoma | 1.06e-03 | 11 | 132 | 2 | C0021367 | |
| Disease | Invasive Ductal Breast Carcinoma | 1.06e-03 | 11 | 132 | 2 | C1134719 | |
| Disease | Pancreatic Neoplasm | 1.08e-03 | 100 | 132 | 4 | C0030297 | |
| Disease | Acute Promyelocytic Leukemia | 1.15e-03 | 46 | 132 | 3 | C0023487 | |
| Disease | Malignant neoplasm of pancreas | 1.16e-03 | 102 | 132 | 4 | C0346647 | |
| Disease | platelet crit | RTEL1 CYP21A2 KDM6B DENND2B KIAA1614 HOXA9 ADO NECTIN2 MARK4 KDM7A SMAD4 PLCE1 | 1.20e-03 | 952 | 132 | 12 | EFO_0007985 |
| Disease | microphthalmia (implicated_via_orthology) | 1.27e-03 | 12 | 132 | 2 | DOID:10629 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | FNDC3B RARA CRIM1 RASA2 KCNB2 FBN1 ADO PTPRG NFATC4 AOPEP NECTIN2 ANKRD11 PAPPA | 1.41e-03 | 1106 | 132 | 13 | EFO_0021796 |
| Disease | Medulloblastoma | 1.47e-03 | 50 | 132 | 3 | C0025149 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 1.50e-03 | 13 | 132 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | body weight | CRIM1 RASA2 SMCHD1 CYP21A2 THSD7B KCNB2 AXIN1 SGK2 SGK3 FBN2 PTPRG NFATC2 NFATC4 PAPPA | 1.58e-03 | 1261 | 132 | 14 | EFO_0004338 |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.74e-03 | 53 | 132 | 3 | C4707243 | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 1.74e-03 | 14 | 132 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | mean arterial pressure | 1.87e-03 | 499 | 132 | 8 | EFO_0006340 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.88e-03 | 195 | 132 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | creatinine measurement, glomerular filtration rate | 1.92e-03 | 117 | 132 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | facial morphology | 1.94e-03 | 55 | 132 | 3 | EFO_0004743 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.94e-03 | 55 | 132 | 3 | C0079744 | |
| Disease | eosinophil percentage of leukocytes | 1.97e-03 | 746 | 132 | 10 | EFO_0007991 | |
| Disease | ovarian cancer (is_implicated_in) | 2.04e-03 | 56 | 132 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | alkaline phosphatase measurement | TMEM176B PSKH1 CYP21A2 WDR81 DENND2B KIAA1614 AXIN1 CRMP1 NFATC4 NECTIN2 MARK4 PLCE1 | 2.05e-03 | 1015 | 132 | 12 | EFO_0004533 |
| Disease | calcium measurement | 2.12e-03 | 628 | 132 | 9 | EFO_0004838 | |
| Disease | asthma, Eczema, allergic rhinitis | 2.17e-03 | 121 | 132 | 4 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | ureidopropionic acid measurement | 2.29e-03 | 16 | 132 | 2 | EFO_0010542 | |
| Disease | bacteriemia | 2.58e-03 | 17 | 132 | 2 | EFO_0003033 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.61e-03 | 61 | 132 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Calcium channel blocker use measurement | 2.76e-03 | 213 | 132 | 5 | EFO_0009930 | |
| Disease | platelet measurement | 3.00e-03 | 315 | 132 | 6 | EFO_0005036 | |
| Disease | ovarian neoplasm | 3.14e-03 | 134 | 132 | 4 | C0919267 | |
| Disease | osteoarthritis | 3.29e-03 | 222 | 132 | 5 | MONDO_0005178 | |
| Disease | Malignant neoplasm of ovary | 3.40e-03 | 137 | 132 | 4 | C1140680 | |
| Disease | serum homoarginine measurement | 3.58e-03 | 20 | 132 | 2 | EFO_0005421 | |
| Disease | Adenocarcinoma of prostate | 3.58e-03 | 20 | 132 | 2 | C0007112 | |
| Disease | Bladder Neoplasm | 3.67e-03 | 140 | 132 | 4 | C0005695 | |
| Disease | ascending aortic diameter | 3.67e-03 | 140 | 132 | 4 | EFO_0021787 | |
| Disease | Malignant neoplasm of urinary bladder | 3.76e-03 | 141 | 132 | 4 | C0005684 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 4.06e-03 | 144 | 132 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.16e-03 | 145 | 132 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | coronary artery calcification | 4.22e-03 | 450 | 132 | 7 | EFO_0004723 | |
| Disease | cortical thickness | ABCA4 CRIM1 KIAA1614 CRMP1 SCUBE1 FBN1 FBN2 ADAMTS7 DOCK7 PRKAG2 PLXNA2 PLCE1 | 4.31e-03 | 1113 | 132 | 12 | EFO_0004840 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RYTGSLTTPPCSEIV | 251 | P23470 | |
| SVLVTPTSDCYNPAA | 351 | Q5U5X8 | |
| PSETDGYVAPLTCSP | 1121 | P04626 | |
| LTPCTSSGADPYVRV | 781 | A0FGR9 | |
| IYASSSPPDTGQRFC | 191 | Q9UGJ0 | |
| CSVPPSDTDTYRAGA | 176 | Q86XL3 | |
| ISYTPRSIPCSLLES | 56 | P55773 | |
| TPRTPSCSADDYADL | 1721 | Q6UB99 | |
| TSDTQCSSVPEPRYG | 1736 | Q96PZ7 | |
| IYPGTSSPAVDRLCV | 1946 | P78363 | |
| YTEASGPCILTPHRD | 176 | Q96SZ5 | |
| RTSCGSPNYAAPEVI | 171 | P54646 | |
| LGTAPSRAYSPACSV | 16 | A0A1B0GTL2 | |
| RSCTETATPLPSQYL | 26 | Q15760 | |
| YTLVVVCSDAGSPEP | 2431 | Q6V0I7 | |
| SDQSGRPCVYTVGSP | 261 | Q8N6M6 | |
| TSSAVCSSPDYLREP | 11 | Q5TGY3 | |
| TYVRCTRSVSIPAPA | 791 | Q9HCK5 | |
| RSPIYPLSDSETSAC | 41 | P78524 | |
| PSTCGVQVYPELESR | 201 | Q9UKP4 | |
| VETPACTLELPTEYG | 381 | Q8TBY9 | |
| KPECSESYTLTPEVG | 171 | P10276 | |
| CDPYATVSLVGPSRN | 191 | Q15283 | |
| YTDTSSPVACRTPVL | 856 | Q8HWS3 | |
| STSPCGDARLHSPYE | 486 | Q9NS39 | |
| CVASPRVTAVPLDSY | 1011 | Q9ULG1 | |
| TVPYSVCVSTAREPS | 241 | Q9ULD8 | |
| YREPLCLSPASSGSS | 161 | Q13469 | |
| FSGSRCELYTAPPST | 1406 | Q04721 | |
| STCSFTYPIRAGNDP | 146 | O43474 | |
| LPTQEPALGTTCYAS | 141 | P20151 | |
| VCPVSRSSNEATSPY | 491 | Q6ZMT4 | |
| ALYCGIRPSNPESSE | 616 | Q71F56 | |
| SYPPCTLTDEETRTE | 776 | Q8N201 | |
| KETTRGPRYCPSIES | 306 | Q9Y2Z2 | |
| IASACGDPETPRTHY | 546 | Q76N89 | |
| PRPEEASVYTSATAC | 1306 | Q9BY66 | |
| DSSVSPAATTACVPY | 371 | O15054 | |
| PLDSRTPCRTAYATT | 736 | Q5VZ46 | |
| VPASCAVSATYERSP | 586 | Q92615 | |
| TTCGTPEYIAPEVLV | 256 | P11801 | |
| RTTRPSSISGYDIPE | 366 | P08686 | |
| YSAPSRFCSTVETPL | 431 | Q86V42 | |
| TCLAPSLTTDYRPGL | 1096 | O75051 | |
| YGVTSRCVTLPLDSP | 351 | Q9ULL4 | |
| SVSPVALDPCSAYIS | 16 | Q8WWZ8 | |
| ALDTVTVPYRLCSSP | 336 | Q9BUK6 | |
| DACDVYADSRPPRST | 111 | A0A1W2PR82 | |
| CSSGTYFPEQSDLEP | 96 | Q9H4H8 | |
| TLSLTDYACGSPPVD | 151 | P31269 | |
| VSPPGVSIASYSRVC | 96 | Q6UWN0 | |
| PGYLCSLSPEELSSV | 446 | Q13421 | |
| TTRTFCGTPDYIAPE | 511 | P05129 | |
| YNGSLTSPPCTDTVD | 231 | P23471 | |
| PVTLSSCQRGETYSP | 1186 | Q13219 | |
| LSSSVRNTCYPEDIP | 1561 | A7KAX9 | |
| PPRGITSSEEYTLCK | 171 | P42694 | |
| ISPVTPEHAGTYRCV | 81 | Q9H7L2 | |
| RTYEVPGTPVCSAKE | 351 | Q9UNX9 | |
| SRVYLECRVTGNPTP | 286 | Q8WX93 | |
| TGLYPASTVCPTRED | 101 | P15976 | |
| YTATTKCSPSVDPER | 296 | Q8NFZ0 | |
| SNPGDTGYCPTRETS | 896 | Q92953 | |
| AYIEGTSTEVPCLPE | 1031 | Q9Y6J0 | |
| TVTYTCNPGPERGVE | 551 | P20023 | |
| STQGPIEVYLCPEET | 341 | O00716 | |
| YSPRDCRTLVSAVPE | 91 | Q96N67 | |
| TSPDGTRCIDVRPGY | 321 | P35555 | |
| SPVCEESYPSVTLRT | 911 | Q9P2H0 | |
| SKPEGCSPEEVITYT | 496 | Q53EP0 | |
| ELVSTDPRPASYSFC | 31 | O15169 | |
| GYSTDVCVPISRLPE | 386 | Q86WU2 | |
| CSYPSSTAVQESPVR | 81 | Q53FE4 | |
| TACPPDSYETQVRLT | 266 | Q9NZV1 | |
| TVPEGYTCVEATPSA | 56 | Q5VZ89 | |
| IRYISDGVECSPPAS | 106 | Q8N4S9 | |
| TYVCTERPGAERPSL | 511 | Q96L34 | |
| DALPPDYSVVRGCTT | 91 | Q6UWN5 | |
| PTSVSCGDVLYLPTS | 31 | Q6PEX3 | |
| CPEAEGSRYVLTSPR | 81 | Q9NQR7 | |
| GDPITTCLSPSVYDI | 6 | Q5T6L9 | |
| TCPPGYVFRTETETC | 836 | P35556 | |
| PATGYEALAEASCPT | 566 | Q8NBF1 | |
| EGTAPSYLENATPCI | 251 | Q9H4W6 | |
| GTSDSYSAPRDCLTP | 691 | Q8N8Z6 | |
| VPDSENSYVLSCGVP | 441 | Q8IWY4 | |
| DTTTTFCGTPEYLAP | 316 | Q96BR1 | |
| PTTPDYLTSLLACGD | 311 | Q14194 | |
| TCYPLESRPSLSLGT | 1936 | Q14980 | |
| CTEGGDYCLIPRTSP | 1021 | Q7Z6I6 | |
| LTCSEQDGSPPSEYT | 151 | Q9Y624 | |
| SERPYSCTPTGRVSS | 6 | Q6ZUA9 | |
| RPTATYCAVTDGIPA | 166 | Q6P087 | |
| SPAAGDPESSLCVEY | 806 | Q9NZ71 | |
| TPTTTVYRCGPLIDL | 246 | P26639 | |
| QTESADGPRTRCPVY | 1226 | Q5T011 | |
| SGFDPECERTTPSIY | 231 | Q9GZN6 | |
| PNLPVYVVDCSSSGT | 976 | A6NHR9 | |
| EPEDTTSTFCGTPEY | 186 | Q9HBY8 | |
| TSTFCGTPEYLAPEV | 191 | Q9HBY8 | |
| NSTVSDVLCIGPPEY | 186 | Q8N0V4 | |
| PQVEAYSPSACSVRG | 586 | Q14934 | |
| STPSVYLGLTDSCQP | 641 | Q86T75 | |
| AVPCNRSGSESAPLY | 1241 | Q9P212 | |
| RSGLCSPSYVAVTPF | 66 | P01106 | |
| VPSSCPIVTVDGYVD | 341 | Q13485 | |
| YERSCDELSPVSPTQ | 1816 | Q9HCD6 | |
| SCPGPRAVTVRYTFT | 241 | B7ZBB8 | |
| SQPEESYCLVVSSPS | 3846 | Q9P2P6 | |
| TVPCPYSSKADVVDS | 241 | Q9H6T0 | |
| LYCSTPTRTAEPAES | 331 | Q8IXU6 | |
| DTVCDRSDPVFPTTG | 161 | Q3YBM2 | |
| LRTSCGSPNYAAPEV | 181 | Q13131 | |
| DIPCRTVTPDASVYS | 61 | Q9ULP9 | |
| YGRPCESLVTFTETP | 81 | P40200 | |
| PGPSEYCPSERTISE | 741 | Q08AE8 | |
| PDSRRPSSCIDIYVS | 1416 | Q9HCF6 | |
| SAYAVCPDITATVTP | 826 | O15067 | |
| PGYTGEDCSTRTCPR | 361 | P22105 | |
| VDPSPDYCLRNESTG | 281 | Q9H1J7 | |
| TPTYPVGTTVEFSCD | 546 | Q53EL9 | |
| YEAAPTSTLTCDSGP | 181 | Q8IV63 | |
| TDPATDCALRGSPVY | 206 | O43548 | |
| PDLTVSRTYSGPICL | 446 | Q6UXZ4 | |
| SSEGDYAIPPDACSL | 536 | Q9ULM0 | |
| CDTAVGTPDYISPEV | 231 | Q13464 | |
| SLPEQSPGYRCRSLT | 6 | Q8N9P0 | |
| NSPDISATRAYTCPV | 461 | Q86T82 | |
| RSSVELPPYSGTVLC | 26 | Q14694 | |
| QEPCSVERGAVYSSP | 786 | Q5QJ38 | |
| RPVDPSFCSSSGYIQ | 976 | Q9C0I4 | |
| IIPTYSLPCSSRSQE | 161 | P0C6A0 | |
| PVGETTQCPSYAREG | 191 | Q562E7 | |
| LPTQEPALGTTCYAS | 141 | P07288 | |
| YICNTDPETDGLSPS | 481 | O75113 | |
| PRIGECLVAPSSYQS | 1536 | B2RTY4 | |
| LSCDVRSNPEPTGYD | 281 | Q92692 |